MedPath

A study to find out the efficiency of pain relief in using esmolol as an adjunct to morphine in breast surgeries.

Phase 4
Completed
Conditions
Health Condition 1: null- Carcinoma Breast
Registration Number
CTRI/2018/05/013571
Lead Sponsor
Government Medical College Kozhikode
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
140
Inclusion Criteria

Patients undergoing Modified Radical Mastectomy falling into ASA criteria 1 & 2

Exclusion Criteria

Male patients for mastectomy

IHD

Bronchial asthma

Bradycardia

Lung disease

Cardiac failure

Patients taking analgesic drugs regularly for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the analgesic efficacy of esmolol given perioperatively in patients undergoing mastectomy under general anesthesia in terms of : <br/ ><br>1)numerical rating scale for pain assessment <br/ ><br>2)time to demand for first rescue analgesic <br/ ><br>3)the number of bolus doses and total opioid consumption in 24 hrs postoperatively.Timepoint: 10 minutes, 2 hours, 6 hours, 12 hours, 24 hours post operatively
Secondary Outcome Measures
NameTimeMethod
To evaluate the hemodynamic stability, any side effects like bradycardia and hypotension.Timepoint: Within 24 hours post surgery
© Copyright 2025. All Rights Reserved by MedPath